Anita Jain on the Tokyo declaration on research integrity

“Raise your hand if:” —“You are an editor of a medical journal?” A sea of hands shot up in the air. —“The ‘Instructions to Authors’ of your journal indicates the reporting guidelines/ checklists to be complied with?” Less than half stay put. — “You do not accept a paper unless the checklist appropriate to the study […]

Read More…

Shalini on India’s antibiotic policy

Antibiotic resistance has become one of the biggest public health epidemics of our time. While national data on hospital acquired infections is still elusive, the Indian government admits that 80% of antibiotics are used in the community, and that 20-50% of all antibiotic use is inappropriate. For some chronic diseases like tuberculosis, the problem of […]

Read More…

Richard Lehman’s journal review—19 August 2013

NEJM  15 Aug 2013  Vol 369 603    A publicly funded trial in the USA, simply called the Prostate Cancer Prevention Trial, examined the effect of finasteride on prostate cancer incidence and mortality in men without known prostate cancer at the time of enrolment, and found that finasteride significantly reduced the risk of prostate cancer, but […]

Read More…

Gabriel Scally: Crumbs from the table for cycling and walking

These days, I worry occasionally about appearing churlish. I fully understand that when some investment in cycling is announced the expected response is that I should applaud politely and feel deep gratitude for the government’s munificence in recognising that cyclists and pedestrians need some support. My problem is that I have never been happy with […]

Read More…

Tessa Richards: How can we get better at listening?

Reports urging health professionals to listen to patients and use their experience to improve the quality, value, and safety of healthcare have been flowing thick and fast. Last week another swelled their ranks. In his report on how the NHS might achieve the Shangri La of causing “zero harm,” US health guru Don Berwick headlined […]

Read More…

Lucien Engelen: Patients not included

We all know that healthcare faces huge challenges—budget cuts, increasing demand, and a shortage of skilled personnel. To help find solutions to this, conferences are set up to discuss the changes needed. But most of these conferences happen without the people they are all about—patients. “When people are talking about you and you’re not at […]

Read More…

Paul J Rosch: Cholesterol, cancer, and statins

Numerous studies of healthy people show that a low cholesterol concentration that has persisted for a decade or more is associated with an increased risk of cancer, and that elevated cholesterol has the reverse effect. This has raised concerns that statins might result in an increase in malignancies, especially since all statins are cardinogenic in doses that […]

Read More…